One-Year Sustained Cellular and Humoral Immunities in Coronavirus Disease 2019 (COVID-19) Convalescents
Jie Zhang,Hao Lin,Beiwei Ye,Min Zhao,Jianbo Zhan,Shaobo Dong,Yaxin Guo,Yingze Zhao,Min Li,Sai Liu,Hangjie Zhang,Wenling Xiao,Yuanyuan Guo,Can Yue,Danni Zhang,Mengjie Yang,Jing Zhang,Chuansong Quan,Weifeng Shi,Xinxue Liu,Peipei Liu,Yongzhong Jiang,Guizhen Wu,George F Gao,William J Liu
DOI: https://doi.org/10.1093/cid/ciab884
IF: 20.999
2021-10-05
Clinical Infectious Diseases
Abstract:Abstract Background The longitudinal antigen-specific immunity in COVID-19 convalescents is crucial for long-term protection upon individual re-exposure to SARS-CoV-2, and even more pivotal for ultimately achieving population-level immunity. We conducted this cohort study to better understand the features of immune memory in individuals with different disease severities at 1 year post–disease onset. Methods We conducted a systematic antigen-specific immune evaluation in 101 COVID-19 convalescents, who had asymptomatic, mild, moderate, or severe disease, through 2 visits at months 6 and 12 after disease onset. The SARS-CoV-2–specific antibodies, comprising neutralizing antibody (NAb), immunoglobulin (Ig) G, and IgM, were assessed by mutually corroborated assays (ie, neutralization, enzyme-linked immunosorbent assay [ELISA], and microparticle chemiluminescence immunoassay [MCLIA]). Meanwhile, T-cell memory against SARS-CoV-2 spike, membrane, and nucleocapsid proteins was tested through enzyme-linked immunospot assay (ELISpot), intracellular cytokine staining, and tetramer staining-based flow cytometry, respectively. Results SARS-CoV-2–specific IgG antibodies, and NAb, can persist among >95% of COVID-19 convalescents from 6 to 12 months after disease onset. At least 19/71 (26%) of COVID-19 convalescents (double positive in ELISA and MCLIA) had detectable circulating IgM antibody against SARS-CoV-2 at 12 months post–disease onset. Notably, numbers of convalescents with positive SARS-CoV-2–specific T-cell responses (≥1 of the SARS-CoV-2 antigen S1, S2, M, and N proteins) were 71/76 (93%) and 67/73 (92%) at 6 and 12 months, respectively. Furthermore, both antibody and T-cell memory levels in the convalescents were positively associated with disease severity. Conclusions SARS-CoV-2–specific cellular and humoral immunities are durable at least until 1 year after disease onset.
immunology,infectious diseases,microbiology